SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-24-000107
Filing Date
2024-05-08
Accepted
2024-05-08 15:56:17
Documents
102
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20240331.htm   iXBRL 10-Q 2322627
2 EX-31.1 pfe-exh311x3312024x10q.htm EX-31.1 9073
3 EX-31.2 pfe-exh312x3312024x10q.htm EX-31.2 9065
4 EX-32.1 pfe-exh321x3312024x10q.htm EX-32.1 4509
5 EX-32.2 pfe-exh322x3312024x10q.htm EX-32.2 4490
  Complete submission text file 0000078003-24-000107.txt   13420037

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20240331.xsd EX-101.SCH 92158
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20240331_cal.xml EX-101.CAL 170794
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20240331_def.xml EX-101.DEF 476363
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20240331_lab.xml EX-101.LAB 972421
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20240331_pre.xml EX-101.PRE 714868
105 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20240331_htm.xml XML 2581655
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 24925659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)